home / stock / rkv:cc / rkv:cc quote
Last: | $0.175 |
---|---|
Change Percent: | 9.37% |
Open: | $0.175 |
Close: | $0.175 |
High: | $0.175 |
Low: | $0.175 |
Volume: | 500 |
Last Trade Date Time: | 05/04/2022 04:56:21 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.175 | $0.175 | $0.175 | $0.175 | $0.175 | 500 | 05-04-2022 |
$0.16 | $0.15 | $0.16 | $0.16 | $0.15 | 20,007 | 05-03-2022 |
$0.17 | $0.15 | $0.17 | $0.17 | $0.15 | 23,270 | 04-27-2022 |
$0.16 | $0.165 | $0.16 | $0.165 | $0.16 | 100,000 | 04-25-2022 |
$0.18 | $0.18 | $0.18 | $0.18 | $0.18 | 2,775 | 04-19-2022 |
$0.18 | $0.18 | $0.18 | $0.18 | $0.18 | 10,000 | 04-13-2022 |
$0.18 | $0.18 | $0.18 | $0.18 | $0.18 | 3,500 | 04-12-2022 |
$0.16 | $0.16 | $0.16 | $0.16 | $0.16 | 10,000 | 04-07-2022 |
$0.18 | $0.18 | $0.18 | $0.18 | $0.18 | 5,854 | 04-04-2022 |
$0.16 | $0.16 | $0.16 | $0.16 | $0.16 | 25,000 | 04-01-2022 |
$0.16 | $0.16 | $0.16 | $0.16 | $0.16 | 10,000 | 03-28-2022 |
$0.16 | $0.175 | $0.16 | $0.175 | $0.16 | 9,500 | 03-24-2022 |
$0.155 | $0.18 | $0.155 | $0.18 | $0.155 | 50,000 | 03-18-2022 |
$0.18 | $0.18 | $0.18 | $0.18 | $0.18 | 100,000 | 03-17-2022 |
$0.18 | $0 | $0.18 | $0 | $0 | 40 | 03-15-2022 |
$0.18 | $0.185 | $0.18 | $0.185 | $0.18 | 10,000 | 03-09-2022 |
$0.18 | $0.18 | $0.18 | $0.18 | $0.18 | 42,000 | 03-07-2022 |
$0.185 | $0.185 | $0.185 | $0.185 | $0.185 | 5,000 | 03-02-2022 |
$0.2 | $0.2 | $0.2 | $0.2 | $0.2 | 7,000 | 02-24-2022 |
$0.185 | $0.2 | $0.185 | $0.2 | $0.185 | 136,070 | 02-22-2022 |
News, Short Squeeze, Breakout and More Instantly...
Rakovina Therapeutics Inc. Company Name:
RKV:CC Stock Symbol:
TSXVC Market:
Rakovina Therapeutics Inc. Website:
VANCOUVER, British Columbia, June 20, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies, is pleased to announce, further to the pres...
VANCOUVER, British Columbia, May 30, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX.V: RKV), (the “Company”) a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for the ...
All monetary figures listed in Canadian Dollars. VANCOUVER, British Columbia, May 24, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“ Rakovina ” or the “ Company ”) (TSX-V: RKV) announces that in accordance with the terms of an indenture ente...